Revathi Rajagopal, MD, MMed

photo of Revathi Rajagopal

Dr. Revathi Rajagopal earned her medical degree in 2002 from the University of Science Malaysia. She completed her pediatrics training in 2010 and her pediatrics hematology and oncology training from University Malaya, Malaysia, in 2015.

She trained in pediatric neuro-oncology at University Malaya Medical Center, Malaysia and subsequently, she also spent time as an observer through the International Learners Program at Hospital for Sick Children, Toronto, and the International Outreach Program at St. Jude Children’s Research Hospital. In 2017, Dr. Rajagopal completed a neuro-oncology fellowship at Princess Margaret Hospital, Perth, Australia.

Dr. Rajagopal returned home and established a dedicated pediatric neuro-oncology multidisciplinary team at the University Malaya Medical Center. There she organized an awareness campaign for health care providers about delayed diagnosis of pediatrics central nervous system tumors. She also implemented changes in management of childhood central nervous system tumors and initiated a Malaysia-Singapore brain tumor board meeting. The monthly online meeting of international neuro-oncologist focuses on complex cases from the Asia-Pacific region.

Dr. Rajagopal currently works as a pediatric hematologist-oncologist at the Hospital Raja Permaisuri Bainun, Ipoh, Malaysia.

She is the 2021-22 Malaysian Society of Pediatric Hematology and Oncology vice president and a member of the Asia Pacific Childhood Cancer Alliance.

Dr. Rajagopal has been involved in the St. Jude Global Academy in Neuro-Oncology, which allowed her to collaborate with the Global Alliance for Pediatric Neuro-Oncology group. Under the mentorship of St Jude, she has coordinated several initiatives to improve the outcomes for children in low- and middle-income countries with tumors of the central nervous system.

“I am a highly motivated and dedicated doctor as well as passionate about childhood cancer care in low- and middle-income countries,” she says. “I am focused on strategies to improve childhood cancer treatment and to increase awareness about childhood cancer among health care providers and the public. My goals are to provide the best possible treatment with compassion, integrity, respect, and equity. I believe the Master of Global Child Health program will provide me with the skills and knowledge to accomplish the St. Jude mission of finding cures and saving children everywhere.”

Hometown: Ipoh, Perak, Malaysia


Pediatric Neuro-oncology Fellowship: Princess Margaret Hospital, Perth, Australia (2017)
Pediatric Hematology-Oncology Fellowship: Royal Children’s Hospital, Melbourne, Australia (2016), University Malaya Medical Center, Malaysia (2012-2015)
Master of Pediatrics (MMED, Paeds): University Malaya, Malaysia (2006 and 2010)
Medical Degree (MD): University Science Malaysia, Malaysia (2002)

Ng YJ, Jalaludin MY, Foo JC, Qaddoumi I, Rajagopal R. Prevalence and risk factors for endocrine disorders in childhood brain tumours from a single tertiary centre in Malaysia. J Pediatr Hematol Oncol 2022 (in press).

Foo JC, Jawin V, Yap TY, Ahmad Bahuri NF, Ganesan D, Mun KS, Loh J, Azman RR, Gottardo NG, Qaddoumi I, Moreira D, Rajagopal R. Conduct of neuro-oncology multidisciplinary team meetings and closing the “gaps” in the clinical management of childhood central nervous system tumors in a middle-income country. Child’s Nervous System 2021.

Rajagopal R, Leong SH, Jawin V, Foo JC, Ahmad Bahuri NF,Mun KS, Azman RR, Loh J, Yap TY, Ariffin H, Moreira D, Gottardo NG, Bouffet E, Ganesan D. Challenges in the Management of Childhood Intracranial Germ Cell Tumors in Middle-Income Countries: A 20-Year Retrospective Review From a Single Tertiary Center in Malaysia. J Pediatr Hematol Oncol 2021.

Ramli N, Lim C, Rajagopal R, Tan LK, Seow PC, Ariffin H. Assessing changes in microstructural integrity of white matter tracts in children with leukaemia following exposure to chemotherapy. Pediatric Radiology 2020.

Moreira D, Rajagopal R, Navarro-Martin R, Polanco AC, Alcasabas AP,  Arredondo-Navarro LA, Campos D, Casavilca-Zambrano C, Diaz Coronado R, Faizal N, Ganesan D, Hamid SA, Khan R, Khu K, Loh J, Lukban M, Negreiros T, Pineda E, Yaqoob N, Zia N, Gajjar A, Rodriguez-Galindo C, Qaddoumi I. Bridging the Gap in Access to Care for Children With CNS Tumors Worldwide. JCO Global Oncology 2020.

Azanan MS, Chandrasekaran S, Rosli E, Chua L, Oh L, Foh CH, Yap TY, Rajagopal R, Rajasuriar R, MacGilliivray T, Trucco E, Ramli N, Kamalden T, Ariffin H. Retinal Vessel Analysis as a Novel Screening Tool to Identify Childhood Acute Lymphoblastic Leukemia Survivors at Risk of Cardiovascular Disease. J Pediatr Hematol Oncol 2020.

Jawin V, Chun F, Hooi T, Rajagopal R. A Rare Entity of S100(−)/cluster of Differentiation 68(+) Jaw Myxoid-Cellular Neurothekeoma: A Case Report and Literature Review. Indian Journal of Paediatric Dermatology 2019.

Chen K, Bridges C, Lynton Z, Lim J, Stringer BW, Rajagopal R, Wong KT, Ganesan D, Ariffin H, Day BW, Richards LJ, Bunt J. Transcription factors NFIA and NFIB induce cellular differentiation in high-grade astrocytoma. Journal of Neuro-Oncology 2019.

Ariffin H, Rahman S, Jawin V, Foo JC, Amram NF, Mahmood NM, Yap TY, Rajagopal R, Lum SH, Chan LL, Lin HP. Haematopoietic stem cell transplantation for inborn errors of immunity: 25‐year experience from University of Malaya Medical Centre, Malaysia. Journal of Paediatrics and Child Health. 2019.

Rajagopal R, Foo JC, Jawin V, Qaddoumi I, Bouffet E. High-dose chemotherapy with autologous stem cell transplantation in infants and young children with ependymoma: A 10-year experience with Head Start II protocol. Pediatric Transplantation. 2019.

 Zhukova N, Rajagopal R, Lam A, Coleman L, Shipman P, Walwyn T, Williams M, Sullivan M, Campbell M, Bhatia K, Gottardo NG, Hansford JR. Use of bevacizumab as a single agent or in adjunct with traditional chemotherapy regimens in children with unresectable or progressive low‐grade glioma. Cancer Med. 2018.

Rajagopal R, Phillips M, Gottardo NG. “Pre-emptive strike”—the case for early treatment of hepatic sinusoidal obstruction syndrome with defibrotide. Pediatr Blood Cancer 2018.

Lassaletta A, Strother D, Laperriere N, Hukin J, Issai Vanan M, Goddard K, Lafay-Cousin L, Johnston DL, Zelcer S, Zapotocky M, Rajagopal R, Ramaswamy V, Hawkins C, Tabori U, Huang A, Bartels U, Bouffet E. Reirradiation in patients with diffuse intrinsic pontine gliomas: The Canadian experience. Pediatr Blood Cancer 2018.

Rajagopal R, Miles G, Kotecha R. High-dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for pediatric primary central nervous system lymphoma in first complete remission. Cancer 2017.

Rajagopal R, Thachil J, Monagle P. Disseminated Intravascular Coagulation in Paediatrics. Arch Dis Child 2016.

 Rajagopal R, Abd-Ghafar S, Ganesan D, Mainudin AZ, Wong KT, Ramli N, Jawin V, Lum SH, Yap TY, Bouffet E, Qaddoumi I, Krishnan S, Ariffin H, Abdullah WA. Challenges of Treating Childhood Medulloblastoma in a Country With Limited Resources: 20 Years of Experience at a Single Tertiary Center in Malaysia. J Glob Oncol 2017.

Rajagopal R, Cheah FC, Monagle P. Thromboembolism and anticoagulation management in the preterm infant. Semin Fetal Neonatal Med 2016.

Strauss A, Furlan I, Steinmann S, Buchholz B, Kremens B, Rossig C, Corbacioglu S, Rajagopal R, Lahr G, Yoshimi A, Strahm B, Niemeyer CM, Schulz A. Unmistakable Morphology? Infantile Malignant Osteopetrosis Resembling Juvenile Myelomonocytic Leukemia in Infants. J Pediatr 2015.

Rajagopal R, Ariffin H, Krishnan S, Abdullah WA, Lin HP. Pediatric Vaginal Yolk Sac Tumor: Reappraisal of Treatment Strategy in a Rare Tumor at a Unique Location. J Pediatr Hematol Oncol 2015.

Lum SH, Chin TF, Lau KH, Yap TY, Rajagopal R, Ariffin H: Refractory acute monoblastic leukemia with low hypodiploidy. Int J Hematol 2014.

Rajagopal R, Lum SH, Jalaludin MY, Krishnan S, Abdullah WA, Ariffin H. Hypercalcaemia: an unusual presenting feature of childhood acute lymphoblastic leukaemia. Br J Haematol 2013.